This study uses the Unpredictable Chronic Mild Stress (UCMS) model to investigate the effects of mid-life stress (MLS) on vascular and neurobiological changes in triple transgenic Alzheimer's disease mice (3xTg-AD) during critical developmental stages.
Objective
To investigate how mid-life stress (MLS) affects cerebrovascular function and AD progression. We hypothesize that chronic stress in 3xTg-AD mice will accelerate cerebrovascular dysfunction and, subsequently, the associated AD pathology.
Methods
Wild-type (WT) and 3xTg-AD mice were subjected to UCMS for 8 weeks at 4 months of age, with physiological, vascular, and molecular outcomes assessed at 6 and 9 months of age. We evaluated cerebrovascular function in the middle cerebral artery (MCA) and measured the expression of key mRNA and protein alterations associated with amyloid-β (Aβ) and tau pathology, which drive AD progression.
Results
Both WT and 3xTg-AD mice exposed to UCMS had significant MCA endothelial dysfunction. Additionally, UCMS accelerated the expression of key AD-related genes, and we observed increased oxidative stress, characterized by higher pro-oxidants and lower antioxidants. Elevated APP and BACE protein levels further suggest that MLS accelerated AD progression.
Conclusions
This study highlights the harmful effects of MLS on cerebrovascular health and the neurobiological mechanisms underlying AD progression. Our findings emphasize the critical link between chronic stress, oxidative dysfunction, and the acceleration of AD progression, offering important insights into potential therapeutic targets for alleviating the impacts of mid-life environmental stressors on AD development.
BreijyehZKaramanR. Comprehensive review on Alzheimer's disease: causes and treatment. Molecules2020; 25: 5789.
2.
BretelerMMClausJJGrobbeeDE, et al.Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. Br Med J1994; 308: 1604–1608.
3.
GelberRPLaunerLJWhiteLR. The Honolulu-Asia aging study: epidemiologic and neuropathologic research on cognitive impairment. Curr Alzheimer Res2012; 9: 664–672.
4.
BagiZKroenkeCDFopianoKA, et al.Association of cerebral microvascular dysfunction and white matter injury in Alzheimer's disease. Geroscience2022; 44: 1–14.
5.
KellyPDenverPSatchellSC, et al.Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer's disease. Angiogenesis2017; 20: 567–580.
6.
SolisEJrHascupKNHascupER. Alzheimer's disease: the link between amyloid-beta and neurovascular dysfunction. J Alzheimers Dis2020; 76: 1179–1198.
7.
YingCKangPBinkleyMM, et al.Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia. Neuroimage Clin2023; 38: 103373.
8.
QuintanaDDAnantulaYGarciaJA, et al.Microvascular degeneration occurs before plaque onset and progresses with age in 3xTg AD mice. Neurobiol Aging2021; 105: 115–128.
9.
CorriveauRABosettiFEmrM, et al.The science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline. Cell Mol Neurobiol2016; 36: 281–288.
10.
HosokiSHansraGKJayasenaT, et al.Molecular biomarkers for vascular cognitive impairment and dementia. Nat Rev Neurol2023; 19: 737–753.
11.
TothPTarantiniSCsiszarA, et al.Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol2017; 312: H1–H20.
SandiCTouyarotK. Mid-life stress and cognitive deficits during early aging in rats: individual differences and hippocampal correlates. Neurobiol Aging2006; 27: 128–140.
14.
TakayanagiYOnakaT. Roles of oxytocin in stress responses, allostasis and resilience. Int J Mol Sci2021; 23: 150.
15.
WheelanNKenyonCJHarrisAP, et al.Midlife stress alters memory and mood-related behaviors in old age: role of locally activated glucocorticoids. Psychoneuroendocrinology2018; 89: 13–22.
16.
BrooksSBranyanKWDeVallanceE, et al.Psychological stress-induced cerebrovascular dysfunction: the role of metabolic syndrome and exercise. Exp Physiol2018; 103: 761–776.
17.
BurrageENCoblentzTPrabhuSS, et al.Xanthine oxidase mediates chronic stress-induced cerebrovascular dysfunction and cognitive impairment. J Cereb Blood Flow Metab2023; 43: 905–920.
18.
Baglietto-VargasDChenYSuhD, et al.Short-term modern life-like stress exacerbates Abeta-pathology and synapse loss in 3xTg-AD mice. J Neurochem2015; 134: 915–926.
19.
ClementAPedersenMMStensballeA, et al.Chronic stress induces NPD-like behavior in APPPS1 and WT mice with subtle differences in gene expression. Genes Brain Behav2021; 20: e12766.
20.
ClementAMadsenMJKastaniegaardK, et al.Chronic stress induces hippocampal mitochondrial damage in APPPS1 model mice and wildtype littermates. J Alzheimers Dis2022; 87: 259–272.
21.
FengYFanJChengY, et al.Stress regulates Alzheimer's disease progression via selective enrichment of CD8(+) T cells. Cell Rep2023; 42: 113313.
22.
NguyenETSelmanovicDMaltryM, et al.Endocrine stress responsivity and social memory in 3xTg-AD female and male mice: a tale of two experiments. Horm Behav2020; 126: 104852.
23.
BelfioreRRodinAFerreiraE, et al.Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice. Aging Cell2019; 18: e12873.
24.
BillingsLMOddoSGreenKN, et al.Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron2005; 45: 675–688.
25.
OddoSCaccamoAShepherdJD, et al.Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron2003; 39: 409–421.
26.
MarkovDDNovosadovaEV. Chronic unpredictable mild stress model of depression: possible sources of poor reproducibility and latent variables. Biology (Basel)2022; 11: 1621.
27.
NolletMLe GuisquetAMBelzungC. Models of depression: unpredictable chronic mild stress in mice. Curr Protoc Pharmacol2013; Chapter 5: Unit 5 65.
28.
FrisbeeJCBrooksSDStanleySC, et al.An unpredictable chronic mild stress protocol for instigating depressive symptoms, behavioral changes and negative health outcomes in rodents. J Vis Exp2015; 106: 53109.
29.
TranIGellnerAK. Long-term effects of chronic stress models in adult mice. J Neural Transm (Vienna)2023; 130: 1133–1151.
30.
MarinMFLordCAndrewsJ, et al.Chronic stress, cognitive functioning and mental health. Neurobiol Learn Mem2011; 96: 583–595.
31.
PeavyGMSalmonDPJacobsonMW, et al.Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults. Am J Psychiatry2009; 166: 1384–1391.
32.
SrivareeratMTranTTAlzoubiKH, et al.Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease. Biol Psychiatry2009; 65: 918–926.
33.
BurrageEMarshallKLSantanamN, et al.Cerebrovascular dysfunction with stress and depression. Brain Circ2018; 4: 43–53.
34.
SherLDGeddieHOlivierL, et al.Chronic stress and endothelial dysfunction: mechanisms, experimental challenges, and the way ahead. Am J Physiol Heart Circ Physiol2020; 319: H488–H506.
35.
FarkasELuitenPG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol2001; 64: 575–611.
36.
VenturelliMPedrinollaABoscolo GalazzoI, et al.Impact of nitric oxide bioavailability on the progressive cerebral and peripheral circulatory impairments during aging and Alzheimer's disease. Front Physiol2018; 9: 169.
37.
Milligan ArmstrongAPorterTQuekH, et al.Chronic stress and Alzheimer's disease: the interplay between the hypothalamic-pituitary-adrenal axis, genetics and microglia. Biol Rev Camb Philos Soc2021; 96: 2209–2228.
38.
MravecBHorvathovaLPadovaA. Brain under stress and Alzheimer's disease. Cell Mol Neurobiol2018; 38: 73–84.
39.
CheignonCTomasMBonnefont-RousselotD, et al.Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol2018; 14: 450–464.
40.
ChenZZhongC. Oxidative stress in Alzheimer's disease. Neurosci Bull2014; 30: 271–281.
41.
Ionescu-TuckerACotmanCW. Emerging roles of oxidative stress in brain aging and Alzheimer's disease. Neurobiol Aging2021; 107: 86–95.
42.
OddoSCaccamoATranL, et al.Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem2006; 281: 1599–1604.
43.
GattaVD'AuroraMGranzottoA, et al.Early and sustained altered expression of aging-related genes in young 3xTg-AD mice. Cell Death Dis2014; 5: e1054.
44.
CucosCAMilanesiEDobreM, et al.Altered blood and brain expression of inflammation and redox genes in Alzheimer's disease, common to APP(V717I) x TAU(P301L) mice and patients. Int J Mol Sci2022; 23: 5799.
45.
HettiarachchiNDallasMAl-OwaisM, et al.Heme oxygenase-1 protects against Alzheimer's amyloid-beta(1–42)-induced toxicity via carbon monoxide production. Cell Death Dis2014; 5: e1569.
46.
ButterfieldDAReedTTPerluigiM, et al.Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res2007; 1148: 243–248.
47.
ForetMKOrcianiCWelikovitchLA, et al.Early oxidative stress and DNA damage in abeta-burdened hippocampal neurons in an Alzheimer's-like transgenic rat model. Commun Biol2024; 7: 861.
48.
HolubiecMIGellertMHanschmannEM. Redox signaling and metabolism in Alzheimer's disease. Front Aging Neurosci2022; 14: 1003721.
49.
LovellMAMarkesberyWR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res2007; 35: 7497–7504.
SotiropoulosICataniaCPintoLG, et al.Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits. J Neurosci2011; 31: 7840–7847.
52.
JinKYaoZvan VelthovenCTJ, et al.Brain-wide cell-type-specific transcriptomic signatures of healthy ageing in mice. Nature2025; 638: 182–196.
53.
Cuadrado-TejedorMRicobarazaAFrechillaD, et al.Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice. J Alzheimers Dis2012; 28: 567–578.
54.
JeongYHParkCHYooJ, et al.Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. FASEB J2006; 20: 729–731.
55.
Shlomi-LoubatonSNitzanKRivkin-NatanM, et al.Chronic stress leads to earlier cognitive decline in an Alzheimer's mouse model: the role of neuroinflammation and TrkB. Brain Behav Immun2025; 127: 303–314.
56.
RothmanSMHerdenerNCamandolaS, et al.3xTgAD Mice exhibit altered behavior and elevated Abeta after chronic mild social stress. Neurobiol Aging2012; 33: 830 e831–812.
57.
CarrollJCIbaMBangasserDA, et al.Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J Neurosci2011; 31: 14436–14449.
58.
HermsJAnlikerBHeberS, et al.Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. EMBO J2004; 23: 4106–4115.
59.
RaiAOjiakorOARylettRJ. Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4. J Neurochem2023; 166: 572–587.
60.
WeyerSWKlevanskiMDelekateA, et al.APP And APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J2011; 30: 2266–2280.
61.
AbidNBNaseerMIKimMO. Comparative gene-expression analysis of Alzheimer's disease progression with aging in transgenic mouse model. Int J Mol Sci2019; 20: 1219.
62.
NagaharaAHMerrillDACoppolaG, et al.Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med2009; 15: 331–337.
63.
BayraktarALamSAltayO, et al.Revealing the molecular mechanisms of Alzheimer's disease based on network analysis. Int J Mol Sci2021; 22: 11556.
64.
ArsenaultDTremblayCEmondV, et al.Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice. Biol Sex Differ2020; 11: 63.
65.
BoriesCGuittonMJJulienC, et al.Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease. PLoS One2012; 7: e46111.
66.
Hirata-FukaeCLiHFHoeHS, et al.Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res2008; 1216: 92–103.
67.
VandalMWhitePJChevrierG, et al.Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease. FASEB J2015; 29: 4273–4284.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
